19.20
-0.88%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Tibet Cheezheng Tibetan Medicine Co
Its shares trade on Shenzhen under the ticker 002287.SZ. It has been listed since 28 August 2009. In the fiscal year to 31 December 2025, it reported revenue of CN¥2.42bn and net income of CN¥646.2m. At that date it held total assets of CN¥6.92bn and shareholders' equity of CN¥4.95bn.
Tibet Cheezheng Tibetan Medicine Co., Ltd. engages in the research, development, production, and sale of Tibetan medicine. The company is headquartered in Nyingchi, Xizang. The company went IPO on 2009-08-28. The firm primarily offers medicines under emplastrum, ointment, granule, crude drugs and others. The firm's products include external pain relieving series, including Cheezheng Xiaotong emplastrum, Qingpeng ointment and Baimai ointment, as well as oral medicine series. The firm distributes its products within domestic market and to overseas markets.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Listed since
- 28 Aug 2009
- Employees
- 2,974
- Website
- cheezheng.com.cn ↗
Leadership
Pay as last reported
- Ms. Jufang LeiChairman of the Board, since 2010CN¥735,600
- Mr. Kailie LiuPresident, Director, since 2014CN¥2.9m
- Ms. Xiaomei YaoChief Financial OfficerCN¥755,300
- Mr. Weiwu ChenChief Scientific Officer, since 2021CN¥954,400
- Ms. Jianqin XiaoVice President - Operations, since 2014CN¥1.2m
- Ms. Ping FengVice President, Secretary of the Board, since 2021CN¥994,400
- Mr. Jun LiVice PresidentCN¥1.5m
- Mr. Zhiqiang WangVice President, since 2010CN¥1.0m
- Mr. Haijian XiaVice PresidentCN¥1.5m
- Ms. Min ZhaoVice PresidentCN¥1.1m
- Mr. Suolang'ouzhu ..DirectorCN¥100,000
- Mr. Xielong LuoDirectorCN¥100,000
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 63
- Environment
- 88
- Social
- 69
- Governance
- 33
- Women in the workforce
- 51.1%
- Carbon reduction policy
- No
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Tibet Cheezheng Tibetan Medicine Co Ltd employs 2974 full-time staff members.
- The company distributes products to domestic and overseas markets effectively.
- Cheezheng Xiaotong emplastrum is a key product in the external pain relieving series.
Weaknesses
- The firm is headquartered in Nyingchi, which may limit local talent access.
- Listing occurred on 28 August 2009, indicating a mature but older market presence.
- Reliance on crude drugs might pose supply chain consistency challenges.
Opportunities
- Expanding the oral medicine series could attract new customer segments.
- Growing demand for traditional Tibetan medicine offers significant international growth potential.
- Increasing research investment could enhance the development of Qingpeng ointment.
Threats
- Intense competition in the global pharmaceutical sector may reduce market share.
- Regulatory changes in China could impact the production of crude drugs.
- Economic fluctuations might decrease consumer spending on Baimai ointment products.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.